Market Tracker

09/30 4:09am ET

IDEXX Laboratories Inc (NASDAQ:IDXX)

111.87
Delayed Data
As of Sep 29
 -1.54 / -1.36%
Today’s Change
63.48
Today|||52-Week Range
115.06
+53.41%
Year-to-Date
ABIOMED Raised to Strong Buy: Should You Add the Stock?
Sep 29 / Zacks.com - Paid Partner Content
CryoLife Hits a 52-Week High on Strong Growth Prospects
Sep 23 / Zacks.com - Paid Partner Content
athenahealth Fights Competition with Saas-Based Approach
Sep 29 / Zacks.com - Paid Partner Content
What's Going on at Idexx Laboratories?
Sep 21 / MotleyFool.com - Paid Partner Content
Abiomed: Heart Pumps Receive Regulatory Approval in Japan
Sep 28 / Zacks.com - Paid Partner Content
Ride the Momentum with These 4 Fast-Moving Stocks
Sep 16 / Zacks.com - Paid Partner Content
Accuray (ARAY) Grapples with Multiple Issues: Dump Now?
Sep 27 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close113.41
Today’s open112.94
Day’s range111.27 - 113.29
Volume369,505
Average volume (3 months)599,721
Market cap$10.2B
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)+14.53%
Earnings growth (this year)+11.90%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.81%
P/E ratio50.6
Price/Sales4.26
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALRAlere Inc-0.41-0.95%
NEOGNeogen Corp-0.94-1.71%
AAAPAdvanced Accelerator...-0.09-0.23%
MYGNMyriad Genetics Inc-0.88-4.08%
Data as of 09/29/2016

Financials

Next reporting dateOctober 21, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$1.6B
Annual profit (last year)$192.1M
Net profit margin11.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts